See more : Oxford Square Capital Corp. – 6 (OXSQZ) Income Statement Analysis – Financial Results
Complete financial analysis of Ganga Pharmaceuticals Limited (GANGAPHARM.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ganga Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Marsh & McLennan Companies, Inc. (MMC) Income Statement Analysis – Financial Results
- PT Pool Advista Finance Tbk (POLA.JK) Income Statement Analysis – Financial Results
- Ipsen S.A. (IPSEY) Income Statement Analysis – Financial Results
- LoopUp Group plc (LOOP.L) Income Statement Analysis – Financial Results
- HHG Capital Corporation (HHGCR) Income Statement Analysis – Financial Results
Ganga Pharmaceuticals Limited (GANGAPHARM.BO)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Ganga Pharmaceuticals Limited
Ganga Pharmaceuticals Ltd. engages in the manufacturing and trading of pharmaceuticals and allied products. It focuses on manufacturing, marketing, and distribution of Bulk Ayurvedic medicines. Its products include Ampachan Vati, Khadira Vati, and Nirmalaya churna. The firm offers acidity, antidandruff, antioxidants, constipation, dental care, diarrhea, ear care, female tonic, and joint pains ayurvedic medicines. The company was founded by Brijmohan C. Sharma in 1974 and is headquartered in Mumbai, India.
Source: https://incomestatements.info
Category: Stock Reports